Study: Weight Loss Drugs Drastically Cut Cancer Risk

Study: Weight Loss Drugs Drastically Cut Cancer Risk
Image copyright: Mario Tama/Staff/Getty Images News via Getty Images

The Spin

Narrative A

The more we examine GLP-1 agonists like Ozempic, the more promise they hold for treating all sorts of ailments. The benefits this drug could provide may be a sea-change in how we treat disease and improve understanding of the underlying mechanisms of the human body itself. Study after study continues to prove the safety and efficacy of this cheap and abundant drug.

Narrative B

Sadly, there is no such thing as a panacea, and we ought to be suspicious of any "cure-all" claims behind a drug poised to make a small group of companies very rich. Lingering financial and scientific questions must be answered, which will take time and money. Diseases like obesity and cancer are complex, multivariate conditions we still do not fully understand.

Metaculus Prediction


Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!